Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to
Cybin (NEO: CYBN) (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed two additional international patent applications; these applications open the possibility for CYBN to obtain patent coverage in 153 countries a
Shares of PepsiCo Inc. (NASDAQ: PEP) traded at a new 52-week high today of $158.81. Approximately 337,000 shares have changed hands today, as compared to an average 30-day volume of 4 million shares.
GlaxoSmithKline PLC (NYSE: GSK) traded at a new 52-week high today of $42.68. This new high was reached on below-average trading volume as 1.4 million shares traded hands, while the average 30-day volume is approximately 3.8 million shares.
Shares of Pfizer Inc. traded today at $51.76, eclipsing its 52-week high. This new high was reached on approximately average trading volume as 31.6 million shares traded hands, while the average 30-day volume is approximately 32.7 million shares.